Area of research
Radiology, Nuclear Medicine and Imaging · Pathology and Forensic Medicine
Research interest
Research interests include Medical Imaging Techniques and Applications, Radiomics and Machine Learning in Medical Imaging, Radiopharmaceutical Chemistry and Applications, and Lymphoma Diagnosis and Treatment.
Radiotherapy and theranostics: a Lancet Oncology Commission
Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0
The RSNA QIBA Profile for Amyloid PET as an Imaging Biomarker for Cerebral Amyloid Quantification
Perspectives on joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards for [18F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors
Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast Cancer
<sup>18</sup>F-FDG PET/CT Radiomic Analysis with Machine Learning for Identifying Bone Marrow Involvement in the Patients with Suspected Relapsed Acute Leukemia
TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast Cancer
Dynamic whole-body PET imaging: principles, potentials and applications
The Use of Quantitative Imaging in Radiation Oncology: A Quantitative Imaging Network (QIN) Perspective
Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point<sup>18</sup>F-FDG PET/CT Imaging in Patients with Advanced Melanoma
Future cancer research priorities in the USA: a Lancet Oncology Commission
Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas
Practical PERCIST: A Simplified Guide to PET Response Criteria in Solid Tumors 1.0
Brown Adipose Reporting Criteria in Imaging STudies (BARCIST 1.0): Recommendations for Standardized FDG-PET/CT Experiments in Humans
Quantitative Imaging in Cancer Clinical Trials
Repeatability of <sup>18</sup>F-FLT PET in a Multicenter Study of Patients with High-Grade Glioma
Metrology Standards for Quantitative Imaging Biomarkers
Generalized whole-body Patlak parametric imaging for enhanced quantification in clinical PET
Summary of the UPICT Protocol for <sup>18</sup>F-FDG PET/CT Imaging in Oncology Clinical Trials
<sup>18</sup>F-FDG PET/CT Qualitative and Quantitative Evaluation in Neurofibromatosis Type 1 Patients for Detection of Malignant Transformation: Comparison of Early to Delayed Imaging With and Without Liver Activity Normalization
Quantitative imaging biomarkers: A review of statistical methods for technical performance assessment
Head and Neck PET/CT: Therapy Response Interpretation Criteria (Hopkins Criteria)—Interreader Reliability, Accuracy, and Survival Outcomes
Optimum Lean Body Formulation for Correction of Standardized Uptake Value in PET Imaging
TBCRC 008: Early Change in <sup>18</sup>F-FDG Uptake on PET Predicts Response to Preoperative Systemic Therapy in Human Epidermal Growth Factor Receptor 2–Negative Primary Operable Breast Cancer
Letter to Cancer Center Directors: Progress in Quantitative Imaging As a Means to Predict and/or Measure Tumor Response in Cancer Therapy Trials
Pre-SBRT metabolic tumor volume and total lesion glycolysis to predict survival in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapy.
Dynamic whole-body PET parametric imaging: I. Concept, acquisition protocol optimization and clinical application
Dynamic whole-body PET parametric imaging: II. Task-oriented statistical estimation
Absolute myocardial flow quantification with 82Rb PET/CT: comparison of different software packages and methods
Relationship of Delayed Enhancement by Magnetic Resonance to Myocardial Perfusion by Positron Emission Tomography in Hypertrophic Cardiomyopathy